|
業務類別
|
Biotechnology |
|
業務概覽
|
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment. |
| 公司地址
| 170 Park Avenue, Florham Park, NJ, USA, 07932 |
| 電話號碼
| +1 908 768-2170 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.celularity.com |
| 員工數量
| 115 |
| Dr. Robert J. Hariri, M.D.,PhD |
Chief Executive Officer and Chairman of the Board |
美元 179.14K |
30/04/2026 |
| Mr. John Sprague |
Acting Chief Financial Officer |
-- |
05/03/2026 |
| Mr. Rick Gonzalez |
Chief Commercial Officer |
-- |
03/06/2026 |
|
|
| Mr. Vincent LeVien |
Director |
30/04/2026 |
| Ms. Diane L. Parks, M.B.A. |
Independent Director |
30/04/2026 |
| Dr. Peter H. Diamandis, M.D. |
Independent Director |
30/04/2026 |
| Dr. Robert J. Hariri, M.D.,PhD |
Chief Executive Officer and Chairman of the Board |
30/04/2026 |
| Dr. Geoffrey Shiu Fei Ling, M.D. |
Independent Director |
30/04/2026 |
|
|
|
|
